Anti-excitotoxic sustained release intraocular implants and related methods
Details for Australian Patent Application No. 2005240081 (hide)
International Classifications
Event Publications
16 November 2006 PCT application entered the National Phase
PCT publication WO2005/107718 Priority application(s): WO2005/107718
24 June 2010 Application Accepted
Published as AU-B-2005240081
21 October 2010 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 28 Sep 2010. Address for service in Australia - Davies Collison Cave 255 Elizabeth Street Sydney NSW 2000
10 February 2011 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 28 Sep 2010
17 February 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005240082-Method and system to remove soluble TNFR1,TNFR2, and IL2 in patients
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser